Virios Therapeutics, Inc. (VIRI) Social Stream
VIRIOS THERAPEUTICS INC (VIRI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering VIRIOS THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 1 | $22 | $22 | $22 | $0.662 | 3223.26% |
| 2022-08-15 | 1 | $22 | $12 | $17 | $0.662 | 2467.98% |
| 2022-09-19 | 1 | $12 | $7 | $9.5 | $0.662 | 1335.05% |
| 2023-05-16 | 1 | $2 | $2 | $2 | $0.662 | 202.11% |
| 2023-11-13 | 1 | $3.5 | $3.5 | $3.5 | $0.662 | 428.7% |
Price Target Last Issued November 15, 2021
The Trend in the Analyst Price Target
Over the past 31 months, VIRI's average price target has gone down $11.5.
Over the past 26 weeks, VIRI's average upside potential has been 201.29%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-16 | 1 | 2.0 | 2.0 | 2.0 | 1.030 | 94.17% |
| 2023-07-24 | 1 | 3.5 | 3.5 | 3.5 | 2.150 | 62.79% |
| 2023-08-15 | 1 | 3.5 | 3.5 | 3.5 | 1.020 | 243.14% |
| 2023-11-13 | 1 | 3.5 | 3.5 | 3.5 | 0.693 | 405.05% |
VIRI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 20 months, VIRI's average broker recommendation rating worsened by 2.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, VIRIOS THERAPEUTICS INC's number of analysts covering the stock is greater than nearly none of them.
- To contextualize these metrics, consider that out of all US stocks, VIRIOS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 573.85% of them.
- In terms of how VIRIOS THERAPEUTICS INC fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -43.17% of that group.
- In terms of how VIRIOS THERAPEUTICS INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 99.79% of that group.
Stocks similar to VIRIOS THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IPA, QLI, and BPTS.
View All Top Stocks by Price Target
Is VIRI a Buy, Hold or Sell? See the POWR Ratings now!